Hilltop National Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$370K Sell
6,422
-2,900
-31% -$167K 0.08% 170
2026
Q1
$565K Buy
9,322
+179
+2% +$10.4K 0.13% 143
2025
Q4
$493K Buy
9,143
+1,012
+12% +$48.7K 0.12% 143
2025
Q3
$367K Hold
8,131
0.09% 165
2025
Q2
$376K Buy
+8,131
New +$399K 0.1% 155
2024
Q4
$454K Hold
8,033
0.14% 135
2024
Q3
$416K Hold
8,033
0.13% 150
2024
Q2
$334K Hold
8,033
0.11% 160
2024
Q1
$436K Buy
+8,033
New +$409K 0.15% 148

Other funds holding BMY

Hilltop National Bank's BMY Position: Q2 2026 in Review

Hilltop National Bank reduced its Bristol-Myers Squibb (BMY) stake by 31% in Q2 2026, selling an estimated $167K and leaving 6,422 shares worth $370K. The position accounts for 0.08% of the portfolio, ranked #170.

Hilltop National Bank first reported a position in BMY in Q1 2024 and has held it in 9 quarters since. The position peaked at $565K in Q1 2026. 888 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Hilltop National Bank held 6,422 shares of Bristol-Myers Squibb worth $370K as of Q2 2026.
  • Hilltop National Bank sold 2,900 Bristol-Myers Squibb shares in Q2 2026, an estimated $167K.
  • Bristol-Myers Squibb made up 0.08% of Hilltop National Bank's portfolio in Q2 2026, its #170 holding.
  • Hilltop National Bank first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 9 quarters since.
  • Hilltop National Bank's Bristol-Myers Squibb position peaked at $565K in Q1 2026.
  • 888 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.